Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteomyelitis | 7 | 2023 | 17 | 1.180 |
Why?
|
| Staphylococcal Infections | 3 | 2023 | 58 | 0.530 |
Why?
|
| Musculoskeletal Diseases | 2 | 2020 | 18 | 0.360 |
Why?
|
| Kidney Diseases | 3 | 2006 | 167 | 0.300 |
Why?
|
| Vitamin D Deficiency | 2 | 2005 | 105 | 0.280 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 610 | 0.280 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 3 | 2018 | 56 | 0.270 |
Why?
|
| Hyponatremia | 1 | 2005 | 6 | 0.260 |
Why?
|
| Hypernatremia | 1 | 2005 | 10 | 0.250 |
Why?
|
| Sodium | 1 | 2005 | 103 | 0.250 |
Why?
|
| Acidosis | 1 | 2004 | 51 | 0.230 |
Why?
|
| Dietary Supplements | 1 | 2005 | 208 | 0.220 |
Why?
|
| Aging | 2 | 2005 | 664 | 0.220 |
Why?
|
| Bacteremia | 1 | 2022 | 30 | 0.210 |
Why?
|
| Child, Preschool | 8 | 2019 | 1418 | 0.210 |
Why?
|
| Orthopedics | 1 | 2020 | 7 | 0.190 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 20 | 0.180 |
Why?
|
| Workflow | 1 | 2019 | 20 | 0.180 |
Why?
|
| Referral and Consultation | 1 | 2020 | 117 | 0.170 |
Why?
|
| Child | 8 | 2022 | 3131 | 0.170 |
Why?
|
| Venous Thrombosis | 1 | 2018 | 28 | 0.160 |
Why?
|
| Weather | 1 | 2018 | 8 | 0.160 |
Why?
|
| Seasons | 1 | 2018 | 112 | 0.150 |
Why?
|
| Acute Disease | 4 | 2022 | 147 | 0.150 |
Why?
|
| Humans | 22 | 2022 | 37093 | 0.140 |
Why?
|
| Retrospective Studies | 5 | 2022 | 2026 | 0.140 |
Why?
|
| Casts, Surgical | 1 | 2016 | 2 | 0.140 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 2016 | 4 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 481 | 0.140 |
Why?
|
| Femoral Fractures | 1 | 2016 | 6 | 0.140 |
Why?
|
| Health Surveys | 3 | 2007 | 373 | 0.130 |
Why?
|
| Nutrition Surveys | 3 | 2008 | 242 | 0.130 |
Why?
|
| Male | 14 | 2020 | 20025 | 0.130 |
Why?
|
| United States | 8 | 2020 | 4223 | 0.130 |
Why?
|
| Female | 14 | 2020 | 20969 | 0.120 |
Why?
|
| Gene Expression Regulation | 2 | 2023 | 1015 | 0.120 |
Why?
|
| Glomerular Filtration Rate | 2 | 2005 | 139 | 0.120 |
Why?
|
| Hypertension | 4 | 2007 | 796 | 0.110 |
Why?
|
| Aged | 7 | 2008 | 6741 | 0.110 |
Why?
|
| Cardiovascular Diseases | 3 | 2008 | 664 | 0.110 |
Why?
|
| Infant | 4 | 2019 | 1046 | 0.110 |
Why?
|
| Staphylococcus aureus | 2 | 2023 | 75 | 0.100 |
Why?
|
| Prospective Studies | 4 | 2019 | 1378 | 0.090 |
Why?
|
| Risk Factors | 5 | 2019 | 3562 | 0.090 |
Why?
|
| Adolescent | 6 | 2019 | 5363 | 0.080 |
Why?
|
| Hypertension, Renal | 1 | 2008 | 16 | 0.080 |
Why?
|
| Middle Aged | 7 | 2008 | 10129 | 0.080 |
Why?
|
| Chronic Disease | 3 | 2006 | 484 | 0.080 |
Why?
|
| Texas | 2 | 2019 | 324 | 0.080 |
Why?
|
| Prevalence | 4 | 2018 | 1455 | 0.070 |
Why?
|
| Albuminuria | 1 | 2006 | 76 | 0.070 |
Why?
|
| Age Factors | 2 | 2007 | 1033 | 0.060 |
Why?
|
| Benzothiadiazines | 1 | 2005 | 3 | 0.060 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2005 | 7 | 0.060 |
Why?
|
| Education | 1 | 2005 | 55 | 0.060 |
Why?
|
| Vasopressins | 1 | 2005 | 13 | 0.060 |
Why?
|
| Water-Electrolyte Balance | 1 | 2005 | 17 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 2 | 2005 | 233 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2005 | 32 | 0.060 |
Why?
|
| Diuretics | 1 | 2005 | 52 | 0.060 |
Why?
|
| Vitamin D | 1 | 2007 | 196 | 0.060 |
Why?
|
| Socioeconomic Factors | 2 | 2006 | 1067 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 974 | 0.060 |
Why?
|
| Acid-Base Equilibrium | 1 | 2004 | 7 | 0.060 |
Why?
|
| Calcium Channel Blockers | 1 | 2004 | 56 | 0.060 |
Why?
|
| Mexican Americans | 1 | 2005 | 189 | 0.060 |
Why?
|
| Poverty | 1 | 2006 | 348 | 0.060 |
Why?
|
| Kidney | 1 | 2005 | 337 | 0.050 |
Why?
|
| Homeostasis | 1 | 2004 | 188 | 0.050 |
Why?
|
| Prognosis | 1 | 2005 | 739 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2004 | 212 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2004 | 215 | 0.050 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2005 | 169 | 0.050 |
Why?
|
| Adult | 5 | 2008 | 11712 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2019 | 36 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2023 | 626 | 0.040 |
Why?
|
| Contrast Media | 1 | 2019 | 92 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 352 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2002 | 646 | 0.040 |
Why?
|
| Pulmonary Embolism | 1 | 2018 | 32 | 0.040 |
Why?
|
| Obesity | 2 | 2007 | 1067 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2002 | 854 | 0.040 |
Why?
|
| Registries | 1 | 2019 | 335 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2019 | 455 | 0.040 |
Why?
|
| Bone Nails | 1 | 2016 | 4 | 0.030 |
Why?
|
| Comorbidity | 1 | 2018 | 623 | 0.030 |
Why?
|
| Radiography | 1 | 2016 | 72 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2015 | 9 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 2008 | 204 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 1130 | 0.030 |
Why?
|
| Incidence | 1 | 2018 | 922 | 0.030 |
Why?
|
| STAT4 Transcription Factor | 1 | 2014 | 3 | 0.030 |
Why?
|
| Resistin | 1 | 2014 | 4 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 175 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 1742 | 0.030 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2014 | 14 | 0.030 |
Why?
|
| Virulence | 1 | 2015 | 223 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2014 | 27 | 0.030 |
Why?
|
| Neutrophils | 1 | 2014 | 131 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2014 | 149 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 149 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 474 | 0.030 |
Why?
|
| Phylogeny | 1 | 2015 | 644 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2016 | 1369 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 767 | 0.020 |
Why?
|
| Algorithms | 2 | 2004 | 465 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 4268 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2006 | 2379 | 0.020 |
Why?
|
| Risk | 1 | 2008 | 267 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2007 | 50 | 0.020 |
Why?
|
| Triglycerides | 1 | 2007 | 138 | 0.020 |
Why?
|
| Animals | 1 | 2023 | 15081 | 0.020 |
Why?
|
| Reference Values | 1 | 2006 | 212 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 583 | 0.020 |
Why?
|
| Data Collection | 1 | 2005 | 194 | 0.010 |
Why?
|
| Sex Factors | 1 | 2007 | 898 | 0.010 |
Why?
|
| California | 1 | 2005 | 476 | 0.010 |
Why?
|
| Diabetic Nephropathies | 1 | 2004 | 61 | 0.010 |
Why?
|
| Indians, North American | 1 | 2005 | 159 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2004 | 191 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 2002 | 52 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 485 | 0.010 |
Why?
|
| Life Style | 1 | 2004 | 308 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2004 | 284 | 0.010 |
Why?
|
| Minority Groups | 1 | 2005 | 596 | 0.010 |
Why?
|
| Motivation | 1 | 2004 | 436 | 0.010 |
Why?
|